GlaxoSmithKline limits Shingrix orders, delays TV commercials amid 'unprecedented' demand

GlaxoSmithKline's new shingles vaccine Shingrix quickly captured the market after winning FDA approval and a preferential recommendation from CDC vaccine advisers, but now strong uptake is leading to supply restrictions. In response, GSK is putting TV advertising on hold, a spokesperson said.